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ABSTRACT: Introduction: Ulcerative colitis (UC) is a chronic inflammatory disease that affects the rectum and colon, involving periods 
of exacerbation and remission. A considerable number of patients requires surgery during the course of this disease. Objective: The purpose 
of this study is to analyze the profile and therapeutic approach of patients with UC. Methods: This is a retrospective study that analyzed 
medical records of patients diagnosed with UC between 1999 and 2010. We selected 45 patients and analyzed the following variables: age, 
gender, ethnic group, interval between onset of symptoms and diagnosis, extraintestinal manifestations, extent of colonic involvement, disease 
complications, pharmacological treatment, indication for surgery, time between diagnosis and indication, surgical procedures, early and late 
complications and pathological results of surgical specimens. Data were analyzed descriptively and compared with other studies. Results: The 
clinical profile of the patients was consistent with the literature. Nine patients underwent surgical treatment: seven were submitted to procto-
colectomy with anastomosis in the ileo-anal pouch and two were submitted to total colectomy; in addition, eight were submitted to ileostomy. 
Postoperative complications occurred in 55.5% of patients. Conclusions: The study confirms data from the literature regarding the profile and 
therapeutic approach of patients with ulcerative colitis.
Keywords: proctocolitis; colorectal surgery; postoperative complications; signs and symptoms, digestive; colonic pouches.
RESUMO: Introdução: A retocolite ulcerativa (RCU) é uma doença inflamatória crônica que acomete reto e cólon, cursando com períodos 
de exacerbação e remissão. Uma parcela considerável de pacientes necessita de procedimento cirúrgico ao longo do curso dessa enfermidade. 
Objetivo: Este estudo objetiva analisar perfil e abordagem terapêutica de portadores de RCU. Métodos: Trata-se de estudo retrospectivo reali-
zado por meio da análise de prontuários de pacientes acompanhados com diagnóstico de RCU no período de 1999 a 2010. Foram selecionados 
45 pessoas, sendo analisadas as variáveis: idade, sexo, raça, intervalo entre início dos sintomas e diagnóstico, sintomatologia, manifestações 
extraintestinais, extensão do acometimento colônico, complicações da doença, tratamento medicamentoso, indicação de cirurgia, tempo entre 
esta e o diagnóstico, procedimentos cirúrgicos, complicações precoces e tardias e resultado anatomopatológico das peças cirúrgicas. Os da-
dos foram analisados de forma descritiva e comparados com outros estudos. Resultados: O perfil clínico dos pacientes foi condizente com a 
literatura. Nove foram submetidos a tratamento cirúrgico, sendo realizadas sete proctocolectomias com anastomose em bolsa íleo-anal e duas 
colectomias totais, além de oito ileostomias. As complicações pós-operatórias ocorreram em 55,5% dos pacientes. Conclusões: O estudo cor-
robora com os dados da literatura referentes ao perfil e abordagem terapêutica dos pacientes com diagnóstico de RCU.
Palavras-chave: proctocolite; cirurgia colorretal; complicações pós-operatórias; sintomas e sinais digestórios; bolsas do colo.
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INTRODUCTION
Ulcerative colitis (UC) is a chronic inflammatory 
bowel disease (IBD) that spreads across the mucosa. 
It involves the rectum in about 95% of the cases and 
may extend in an ascending, symmetrical form, pre-
senting a circumferential pattern, fully or partially af-
fecting the colon1,2. It affects around 500,000 people 
in the United States, with annual incidence of 8 to 
12 in 100,000 people, a constant index in the last five 
decades1. In Brazil, no concrete data are available, but 
growing incidence of the disease has been observed. It 
is the cause of 25,000 doctor’s appointments annual-
ly, around 30,000 hospital admissions and over 1 mil-
lion working days missed by people with this disease1. 
Its etiology is unknown, but it is believed to involve 
multiple factors, with patients genetically susceptible, 
associated with unbalanced immunological response, 
influenced by environmental factors1,2.
It is clinically characterized by diarrhea mixed with 
blood, associated with symptoms of rectal urgency and te-
nesmus. The clinical course of the disease involves periods 
of exacerbation and remission, which may occur spon-
taneously or as a response to treatment3. Most treatments 
use pharmacological options; however, estimates say that 
around 20 to 30% of the affected individuals will require 
surgical interventions, which may be curative, with most of 
them within the period of 10 years from the initial diagno-
sis. The surgery has elective or emergency indication 
when it occurs as a result of disease complications2.
When the disease has indication for surgery, the 
intervention is selected from a number of surgical op-
tions. The benefits of a more extensive procedure that 
enhances the disease cure, reduces the long-term risk 
of cancer and improves the functional result should 
be analyzed versus a less extensive procedure, which 
may be safer in specific clinical situations. It is impor-
tant to emphasize that most patients want to avoid a 
definitive ileostomy. In addition, the development of 
an intestinal restorative technique with ileal pouch-
anal anastomosis (IPAA) is the procedure of choice to 
treat patients with UC4.
The purpose of this study was to analyze the pro-
file and therapeutic approach of patients with UC from 
1999 to 2010 seen at the Service of Gastroenterology and 
Coloproctology of the Hospital Universitário Onofre 
Lopes (HUOL), in Natal, comparing the results with 
those presented in the medical literature, for possible 
practice reviews.
METHODS
This is a retrospective study based on chart re-
views of patients diagnosed with ulcerative colitis 
seen at the Service of Gastroenterology and Coloproc-
tology of the HUOL from 1999 to 2010.
A bibliographic review regarding the disease was 
performed, using Pubmed, Lilacs and Scielo database.
The variables collected were: age, gender, race, 
interval between onset of symptoms and diagnosis, 
extraintestinal manifestations, extent of colonic in-
volvement, disease-related complications, pharmaco-
logical treatment, indication for surgery, time between 
diagnosis and surgical indication, surgical procedures, 
early and late postoperative complications (up to 30 
days and more than 30 days after the surgery, respec-
tively) and pathological results of surgical specimens.
Fifty-three patients were found and 45 of them 
were selected for this study. The exclusion criterion 
was the inadequate completion of patient records.
Data collected were stored in Microsoft Excel 
2007TM spreadsheets for the analysis of variables, elab-
oration of charts and tables and subsequent comparison 
with data published in the global medical literature.
The protocol of this study was approved by the 
Research Ethics Committee of the HUOL, with a 
certificate CAAE (Certificado de Apresentação para 
Apreciação Ética) nº 0069.0.294.000-11.
RESULTS
The analysis of 45 patient records showed that 
both genders were affected, with a small predomi-
nance in men (53.33%; n=24). The most affected age 
group was over 40 years of age (57.78%; n=26), fol-
lowed by the age group between 31 and 40 years old 
(28.89%; n=13). The group between 21 and 30 years 
old represented 8.89% (n=4) of patients and the group 
of patients under 20 years old, 4.44% (n=2), as illus-
trated in Chart 1. Regarding the onset of symptoms 
and diagnosis, the predominance was in the group 
between 31 and 40 years old and above 60 years old.
In terms of race, white patients were predomi-
nant (51%; n=23), followed by brown patients 
(42.2%; n=19) and, in a small proportion, black pa-
tients (6.7%; n=3), no indigenous patient was included 
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in the study. Positive family history was observed in 
7% of the cases.
The main symptoms presented were chronic di-
arrhea and bleeding of variable intensity, both present-
ed in 100% of the cases. Other important symptoms 
were: weight loss (86.67%), followed by abdominal 
pain, tenesmus and anorexia, in equal proportions 
(73.33%). The patients presented other symptoms, as 
illustrated in Chart 2.
Extraintestinal manifestations were present in 
35.56% (n=16) of the patients, with predominance 
of osteoarticular manifestations, followed by der-
matological manifestations and, in small propor-
tions, by ophthalmic, hepatobiliary, nutritional and 
metabolic manifestations.
From all patients, 13.33% (n=6) had complica-
tions related to UC, such as rectal bleeding, fulminant 
colitis, toxic megacolon, perforation, delayed growth 
and dysplasia (Table 1).
The predominant UC location was the distal co-
lon (proctitis/proctosigmoiditis), in 53.33% (n=24) of 
the cases, followed by left colitis in 26.67% (n= 12) 
and pancolitis in 20% (n=9) (Chart 3).
In terms of treatment, the most frequent medi-
cations were salicylates (82.22%), oral corticoste-
roids (51.11%) and, in small proportions, azathio-
prine, infliximab, antibiotics, topical corticosteroid 
and tacrolimus (Table 2).
Twenty per cent of patients (n=9) had indica-
tion for surgery, 67% (n=6) of them were submitted to 
elective surgery and 33% (n=3) to emergency surgery.
Table 1. Complications of ulcerative colitis.
Complications Absolute value
Relative 
value (%)
Present 6 13.33
Absent 39 86.67
Total 45 100.00
Types of 
complications
Bleeding 3 6.67
Perforation 2 4.44
Fulminant colitis/
toxic megacolon 3 6.67
Delayed growth 1 2.22
Cancer/dysplasia 1 2.22
Total patients 6 13.33
Chart 1. Distribution of patients according to age group and 
comparison of age group with the age at onset of symptoms.
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Chart 3. Location of ulcerative colitis.
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Table 2. Drugs used in the clinical treatment.
Pharmacological 
treatment
Absolute 
value
Relative  
value (%)
Salicylates 37 82.22
Oral corticosteroids 23 51.11
Budesonide 2 4.44
Azathioprine 5 11.11
Antibiotics 4 8.89
Infliximab 4 8.89
Tacrolimus 1 2.22
Total patients 45
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In all cases, the interval between diagnosis and 
indication for surgery was 10 years or less, in the ma-
jority of cases the interval was within the first five 
years of the disease (Chart 4).
The indications that led to surgery were clinical 
intractability (67%; n=6), side effects/drug intolerance 
(22%; n=2) and dysplasia (11%; n=1) (Chart 5).
Among surgical procedures, total proctocolecto-
my with “J” ileal pouch-anal anastomosis was the most 
common procedure (78%; n=7), followed by total col-
ectomy (22%; n=2) (Chart 6). Six patients with a ileal 
pouch-anal anastomosis underwent diverted ileostomy.
Postoperative complications occurred in 55.5% 
(n=5) of the patients, four patients had early compli-
cations (<30 days), and late (>30 days) complications 
were observed in five patients. The main early compli-
cations were: anastomotic dehiscence (two patients), 
pelvic/abdominal sepsis (two) and bleeding (one). 
Late complications were: pouch fistula (two), pouchi-
tis (two), IPAA stenosis (one), anal fistula (one) and 
death (one) (Chart 7).
After the anatomopathological analysis, UC di-
agnosis was confirmed in 89% (n=8) of the cases and 
Crohn’s disease in one patient (11%; n=1), who was 
later submitted to abdominoperineal amputation due 
to the presence of disease in the rectal stump and dys-
plasia during the follow-up period.
DISCUSSION
The disease extension was, in descending order, 
distal colitis, left-side colitis and pancolitis. These 
data are compatible with those found in the medical 
literature, which show predominance of distal colitis 
in 34 to 70% of the cases, followed by left colitis in 8 
to 40% and pancolitis in 14 to 56%1.
Extraintestinal manifestations (EIM) may occur 
in up to 30% of the cases – ophthalmic manifestations, 
arthritis and dermatological manifestations are associ-
ated with the disease activity, while axial arthropathy 
and primary sclerosing cholangitis (PSC) occur re-
gardless of the disease activity1. In our study, EIMs 
occurred in 35.5%.
According to international references, the most 
common drugs used to induce remission of acute dis-
ease are salicylates and corticosteroids and, in more 
severe or refractory cases, thiopurines, azathioprine, 
6-mercaptopurine and immunobiological agents (inf-
liximab). For maintenance, salicylates, thiopurines and 
immunobiological agents are the most recommended 
drugs1,5. Our study has agreed with the literature, as 
salicylates were the most common drugs, followed by 
oral corticosteroids, azathioprine and infliximab.
Chart 4. Period between diagnosis and surgery indication.
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Regarding the treatment, we had 20% of surgi-
cal indication (n=9), all within the first 10 years of the 
disease, with predominance (77%) in the first 5 years. 
These results are similar to current literature, which in-
dicates that 20 to 30% of patients with UC are submit-
ted to surgical resection, most of them within the first 
10 years from the initial diagnosis1,2,4-6. The progress of 
surgical techniques has allowed fecal stream restora-
tion with anal continence preservation, reinforcing the 
importance of surgery in UC cure. The indications for 
surgery in our study were clinical intractability (67%), 
drug intolerance (22%) and dysplasia (11%). Among 
these patients, 67% (n=6) were submitted to elective 
surgery and 33% (n=3) to emergency surgery due to 
UC complications (fulminant colitis, toxic megaco-
lon, perforation and bleeding). One patient submitted 
to elective surgery had delayed growth. Such indica-
tions are reported in the medical literature1,2,4,5.
In patients that developed peritonitis or perfora-
tion due to toxic colitis refractory to clinical treatment, 
the surgery performed was subtotal colectomy with il-
eostomy. Better medical support and more aggressive 
surgical intervention led to significant reduction of 
mortality caused by toxic colitis to levels below 3%4,7. 
Bleeding occurred in 10% of all emergency colectomy 
for UC. In patients with massive bleeding and mal-
nourished, the best option is subtotal colectomy and 
terminal ileostomy4.
Around 70% of the patients with UC are submit-
ted to surgery due to chronic problems4. These peo-
ple have persistent symptoms, with negative impact 
on their quality of life. Malnourishment and delayed 
growth are significant problems in pediatric patients. 
In more severe chronic cases, restorative proctocolec-
tomy is frequently performed in stages. Debilitating 
extraintestinal manifestations are rarely indications 
for colectomy. Although most of these conditions will 
spontaneously improve in the postoperative period, 
the response is not always predictable. Long-term 
complications from the use of steroids are another fre-
quent indication for surgical resection4.
Among patients with UC, 10% are submitted to 
surgery due to cancer or dysplasia4. The risk factors 
for the development of colorectal cancer are long-
term disease, pancolitis, early age at onset, concomi-
tant PSC and dysplasia. Dysplasia is still the main risk 
factor available for malignancy potential, and it is rea-
sonable for patients with UC for more than eight years 
to be submitted to surveillance colonoscopy with se-
quential biopsy. Patients diagnosed with dysplasia or 
cancer should be submitted to surgical resection1,4,5,8.
Proctocolectomy with “J” ileal pouch-anal anas-
tomosis was performed in six patients and urgent total 
colectomy in three patients in our study. One patient 
was submitted to permanent ileostomy, after the anato-
mopathological diagnosis of Crohn’s disease, and one 
patient to temporary ileostomy due to toxic colitis, with 
subsequent intestinal reconstruction with IPAA.
With the advent of restorative proctocolecto-
my with IPAA as the procedure of choice, total col-
ectomy with ileostomy has been mainly indicated to 
emergency cases, incontinent patients and cases of in-
determined colitis4. Many studies indicate that a restor-
ative proctocolectomy with IPAA can be performed in 
a safer manner, with operative mortality less than 1%. 
Postoperative complications are frequent, but control-
lable. They are of mechanical, inflammatory, func-
tional, neoplastic and metabolic nature, ranging from 
10 to 60%9.
The main early postoperative complications pre-
sented in this study were anastomotic dehiscence, pel-
vic/abdominal sepsis and bleeding, and late complica-
tions were pouch fistula, pouchitis, IPAA stenosis, anal 
fistula and death. All these results are similar to those 
of other studies published in the medical literature4,10.
Sepsis occurs in 3 to 15% of patients after restor-
ative proctocolectomy with IPAA, and it is the most 
frequent early complication4,10. The causes include 
pouch or anastomotic leak, with consequent contam-
ination of peritoneal cavity, and it may affect up to 
34% of the cases11 and lead to death in 3%10,11. Other 
less frequent complications include deep vein throm-
bosis, pulmonary embolism, intestinal bleeding from 
ileostomy or pouch and pouch ischemia.
Pouchitis is the most frequent late complication, 
affecting 23 to 46% of patients4,10. In this situation, 
clinical treatment is indicated and, in some cases, ileal 
bypass or pouch excision is necessary. Pouch fistulas 
occur in 3 to 17% of the cases4,10 and stenosis of the 
pouch anastomosis in 7.8 to 14%4,10,12.
In our study, all ileal pouches were constructed in 
“J” shape, as recommended by other studies13, and, in 
six cases, a diverted ileostomy was performed, despite 
its controversial indication in medical literature14. Al-
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though diverted ileostomy does not prevent dehis-
cence, it minimizes the degree of pelvic contamina-
tion, which may result in pouch dysfunction, requiring 
pouch removal. Some authors emphasize the benefit 
of protective ileostomy in specific cases4.
When analyzing the long-term functional results 
of the pouch and the quality of life of patients after re-
storative proctocolectomy, we can say that, according 
to prior studies, most patients are satisfied15,16. In our 
study, all of our patients are in outpatient clinic follow-
up, with good function and excellent pouch acceptance.
CONCLUSION
After analyzing data from this case series, we can 
conclude that our study results are similar to those re-
ported in the medical literature and this was important 
to review the care delivered in our service.
